Identification, structure-activity relationships and molecular modeling of potent triamine and piperazine opioid ligands.
暂无分享,去创建一个
Austin B. Yongye | Karina Martínez-Mayorga | Adel Nefzi | Austin B Yongye | Marc A Giulianotti | Richard A Houghten | J. Medina-Franco | M. Giulianotti | R. Houghten | A. Yongye | K. Martínez-Mayorga | J. Appel | C. Dooley | A. Nefzi | Jose L Medina-Franco | Jon R Appel | Colette T Dooley | J. Medina‐Franco
[1] Clemencia Pinilla,et al. Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods. , 2008, Journal of combinatorial chemistry.
[2] G. Koob,et al. Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists , 1992, Neuropharmacology.
[3] Marvin Johnson,et al. Concepts and applications of molecular similarity , 1990 .
[4] David M. Ferguson,et al. Molecular recognition of opioid receptor ligands , 2006, The AAPS Journal.
[5] M. Eguchi. Recent advances in selective opioid receptor agonists and antagonists , 2004, Medicinal research reviews.
[6] Clemencia Pinilla,et al. Advances in the use of synthetic combinatorial chemistry: Mixture-based libraries , 2003, Nature Medicine.
[7] R. Lahti,et al. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist. , 1983, The Journal of pharmacology and experimental therapeutics.
[8] R. Houghten,et al. Selective Ligands for the μ, δ, and κ Opioid Receptors Identified from a Single Mixture Based Tetrapeptide Positional Scanning Combinatorial Library* , 1998, The Journal of Biological Chemistry.
[9] G. Uhl,et al. Human kappa opiate receptor second extracellular loop elevates dynorphin's affinity for human mu/kappa chimeras. , 1994, The Journal of biological chemistry.
[10] C. Mathias,et al. Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution , 1989, British journal of pharmacology.
[11] M. Ivanovic,et al. Steric interactions and the activity of fentanyl analogs at the mu-opioid receptor. , 2006, Bioorganic & medicinal chemistry.
[12] David M. Ferguson,et al. A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist , 2006, J. Comput. Aided Mol. Des..
[13] Clemencia Pinilla,et al. Conformation-opioid activity relationships of bicyclic guanidines from 3D similarity analysis. , 2008, Bioorganic & medicinal chemistry.
[14] Jürgen Bajorath,et al. Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. , 2007, Drug discovery today.
[15] J. Mccall,et al. [3H]U-69593 a highly selective ligand for the opioid κ receptor , 1985 .
[16] S. Muchmore,et al. The Use of Three‐Dimensional Shape and Electrostatic Similarity Searching in the Identification of a Melanin‐Concentrating Hormone Receptor 1 Antagonist , 2006, Chemical biology & drug design.
[17] Clemencia Pinilla,et al. A Similarity‐based Data‐fusion Approach to the Visual Characterization and Comparison of Compound Databases , 2007, Chemical biology & drug design.
[18] T. Yaksh,et al. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. , 1984, The Journal of pharmacology and experimental therapeutics.
[19] J. Jenkins,et al. A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes. , 2004, Journal of medicinal chemistry.
[20] H. Mosberg,et al. Direct dependence studies in rats with agents selective for different types of opioid receptor. , 1988, The Journal of pharmacology and experimental therapeutics.
[21] José L. Medina-Franco,et al. Characterization of Activity Landscapes Using 2D and 3D Similarity Methods: Consensus Activity Cliffs , 2009, J. Chem. Inf. Model..
[22] Irina D. Pogozheva,et al. Homology modeling of opioid receptor-ligand complexes using experimental constraints , 2005, The AAPS Journal.
[23] P. Portoghese,et al. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. , 1991, The Journal of pharmacology and experimental therapeutics.
[24] J. Leander. A kappa opioid effect: increased urination in the rat. , 1983, The Journal of pharmacology and experimental therapeutics.
[25] R. Hill,et al. Pharmacological profile of PD 117302, a selective κ‐opioid agonist , 1987 .
[26] S. Filipek,et al. Molecular Dynamics of µ Opioid Receptor Complexes with Agonists and Antagonists , 2008 .
[27] P. Hawkins,et al. Comparison of shape-matching and docking as virtual screening tools. , 2007, Journal of medicinal chemistry.
[28] R A Houghten,et al. Mixture-based synthetic combinatorial libraries. , 1999, Journal of medicinal chemistry.
[29] Matthew J Sykes,et al. Prediction of metabolism by cytochrome P450 2C9: alignment and docking studies of a validated database of substrates. , 2008, Journal of medicinal chemistry.
[30] Gerhard Klebe,et al. Ligand-supported homology modeling of g-protein-coupled receptor sites: models sufficient for successful virtual screening. , 2004, Angewandte Chemie.
[31] J. Simon,et al. The kappa-opioid receptor: evidence for the different subtypes. , 1993, Life sciences.
[32] Richard A. Houghten,et al. Solid-Phase Synthesis of Substituted 2,3-Diketopiperazines from Reduced Polyamides , 2000 .
[33] Yongping Yu,et al. Combinatorial chemistry: libraries from libraries, the art of the diversity-oriented transformation of resin-bound peptides and chiral polyamides to low molecular weight acyclic and heterocyclic compounds. , 2004, The Journal of organic chemistry.
[34] D. Ferguson,et al. Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor. , 2000, Journal of medicinal chemistry.
[35] Y. Martin,et al. Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.
[36] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[37] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[38] M. E. Lewis,et al. Anatomy of CNS opioid receptors , 1988, Trends in Neurosciences.